Results 111 to 120 of about 4,295 (215)

Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-induced Nausea and Vomiting in Children with Cancer [PDF]

, 2016
Basch, Bauters, Bodge, Chanthawong, Choi, Choo, Dupuis, Dupuis, Dupuis, Dupuis, Flank, Flank, Gardani, Gore, Guyatt, Guyatt, Hachimi-Idrissi, Hesketh, Higi, Kaiser, Kang, Massa, McCabe, Musso, Navari, Sanofi-Aventis Canada Inc, Schnell, Shillingburg, Shiu, Smith, Smith, Wit   +31 more
core   +1 more source

Publication Only

HemaSphere, Volume 9, Issue S1, June 2025.
wiley   +1 more source

Prevention of acute chemotherapy-induced nausea and vomiting: the role of palonosetron

Cancer Management and Research, 2009
Emilio Bajetta, Sara Pusceddu, Valentina Guadalupi, Monika Ducceschi, Luigi CelioMedical Oncology Unit 2, Fondazione IRCCS “Istituto Nazionale dei Tumori”, Milan, ItalyAbstract: Prevention of nausea and vomiting is the main goal of ...
Emilio Bajetta, Sara Pusceddu, Valentina Guadalupi, et al   +3 more
doaj  

Profile of netupitant/palonosetron (NEPA) fixed dose combination and its potential in the treatment of chemotherapy-induced nausea and vomiting (CINV)

Drug Design, Development and Therapy, 2014
Rudolph M Navari Cancer Care Program, Eastern Europe, World Health Organization, Mishawaka, IN, USA; Indiana University School of Medicine, South Bend, IN, USA; South Bend Medical Services Corporation, IN, USA Abstract: Chemotherapy-induced ...
Navari RM
doaj  

Informe técnico palonosetron inyectable

, 2013
Revisada la evidencia observamos una ventaja de hasta 19% en disminución en emesis aguda en regímenes altamente emetogénicos. Respecto a la seguridad es similar a la terapia estándar aunque reportes muestran una cierta ventaja respecto a la prolongación del intervalo QT, sin embargo las múltiples interacciones medicamentosas por el CYP3A4 y CYP2C9 ...
openaire   +2 more sources

Comparative Efficacy of Palonosetron-Dexamethasone Versus Granisetron-Dexamethasone for Prevention of Postoperative Nausea and Vomiting: A Review With Focus on Otologic Surgeries. [PDF]

Cureus
Bairwa K, Kewalramani R, Vaswani A, Somvanshi M, Bairwa S.   +4 more
europepmc   +1 more source

Granisetron transdermal delivery system versus palonosetron in the prevention of long-delayed nausea and vomiting: a phase III randomized trial. [PDF]

Oncologist
Liu X, Meng Y, Du Y, Mu Y, Li G, Li H, Guan X, Zhang J.   +7 more
europepmc   +1 more source

Bioequivalence of netupitant and palonosetron (NEPA) oral suspension and hard capsules in healthy individuals: results from an open-label, randomized, two-treatment, four-period, two-sequence replicative design trial. [PDF]

Support Care Cancer
Gasanin E, Bezzo R, Spinelli T, Seitz F.
europepmc   +1 more source

The effect of preoperative PC6 intradermal acupuncture combined with dexamethasone and palonosetron on preventing postoperative nausea and vomiting in bilateral orthognathic surgery: a research protocol for blind, double-dummy, randomized controlled clinical trial. [PDF]

Front Med (Lausanne)
Xu X, Yin C, Cai J, Li J, Li J, Li Z.
europepmc   +1 more source

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy [PDF]

, 2016

core   +1 more source